Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,565,020
+$88,658,460 QoQ
Shares Held
3,377,000
+317.9% QoQ
Ownership
2.00%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#20
of 247 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. TNGX ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in TNGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,565,020 | 3,377,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,906,560 | 808,153 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $4,545,490 | 513,035 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $11,007,513 | 1,111,870 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $27,237,579 | 2,418,968 | Shares | Sole | 2023-11-14 | |
| 2021-06-30 BCTG | — | 500,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 BCTG | — | 500,000 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 BCTG | — | 500,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 BCTG | — | 500,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||